Wealth Quarterback LLC Cel Sci Corp Transaction History

Wealth Quarterback LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.58 - $4.99 $1,199 - $2,320	-465 Closed	0 $0
Q3 2021 Nov 17, 2021	SELL	$7.64 - $12.49 $1,910 - $3,122	-250 Reduced 34.97%	465 $6,000
Q2 2021 Aug 11, 2021	BUY	$8.68 - $27.49 $6,206 - $19,655	715 New	715 $7,000
Q2 2020 Aug 17, 2020	SELL	$9.75 - $17.6 $7,117 - $12,848	-730 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$7.54 - $17.05 $10,292 - $23,273	-1,365 Reduced 65.16%	730 $8,000
Q4 2019 Feb 27, 2020	BUY	$6.71 - $9.55 $14,057 - $20,007	2,095 New	2,095 $19,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $30.4M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Quarterback LLC with notifications on news.